Recent statutory changes have opened the door for a modest increase in qui tam actions over the last several years, a development that coincides with an increase in big-dollar recoveries.
April 28, 2014 at 02:03 PM
1 minute read
Recent statutory changes have opened the door for a modest increase in qui tam actions over the last several years, a development that coincides with an increase in big-dollar recoveries.
Last November, Zane Memeger, U.S. attorney for the Eastern District of Pennsylvania, announced a record settlement for a single drug, the antipsychotic Risperdal, that was part of a $2.2 billion global accord with subsidiaries of Johnson & Johnson.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
